Directrices para presentación de informes de ensayos clínicos sobre intervenciones con inteligencia artificial: extensión CONSORT-AI

Translated title of the contribution: Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension

Grupo de Trabajo SPIRIT-AI y CONSORT-AI

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

The CONSORT 2010 statement provides minimum guidelines for reporting randomized trials. Its widespread use has been instrumental in ensuring transparency in the evaluation of new interventions. More recently, there has been a growing recognition that interventions involving artificial intelligence (AI) need to undergo rigorous, prospective evaluation to demonstrate impact on health outcomes. The CONSORT-AI (Consolidated Standards of Reporting Trials–Artificial Intelligence) extension is a new reporting guideline for clinical trials evaluating interventions with an AI component. It was developed in parallel with its companion statement for clinical trial protocols: SPIRIT-AI (Standard Protocol Items: Recommendations for Interventional Trials–Artificial Intelligence). Both guidelines were developed through a staged consensus process involving literature review and expert consultation to generate 29 candidate items, which were assessed by an international multi-stakeholder group in a two-stage Delphi survey (103 stakeholders), agreed upon in a two-day consensus meeting (31 stakeholders) and refined through a checklist pilot (34 participants). The CONSORT-AI extension includes 14 new items that were considered sufficiently important for AI interventions that they should be routinely reported in addition to the core CONSORT 2010 items. CONSORT-AI recommends that investigators provide clear descriptions of the AI intervention, including instructions and skills required for use, the setting in which the AI intervention is integrated, the handling of inputs and outputs of the AI intervention, the human–AI interaction and provision of an analysis of error cases. CONSORT-AI will help promote transparency and completeness in reporting clinical trials for AI interventions. It will assist editors and peer reviewers, as well as the general readership, to understand, interpret and critically appraise the quality of clinical trial design and risk of bias in the reported outcomes.

Translated title of the contributionReporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension
Original languageSpanish
JournalRevista Panamericana de Salud Publica/Pan American Journal of Public Health
Volume48
DOIs
StatePublished - 2024

Funding

participantes en el estudio Delphi y el estudio piloto (Nota com-plementaria); a E. Marston (Universidad de Birmingham, Reino Unido) por su apoyo estrat\u00E9gico; a C. Radovanovic (University Hospitals Birmingham NHS Foundation Trust, Reino Unido) y A. Walker (Universidad de Birmingham, Reino Unido) por el apoyo administrativo. Las opiniones expresadas en esta publi-caci\u00F3n son las de los autores, participantes en el Delphi y de las partes interesadas y pueden no representar las opiniones de la instituci\u00F3n anfitriona. Este trabajo ha sido financiado por Wellcome Trust Institutional Strategic Support Fund: Digital Health Pilot Grant, Research England (parte de investigaci\u00F3n e innovaci\u00F3n del Reino Unido), Health Data Research UK y a Alan Turing Institute.

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Fingerprint

Dive into the research topics of 'Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension'. Together they form a unique fingerprint.

Cite this